<!DOCTYPE html>
<html lang="en">

<head>

    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="description" content="AMR, drug resistance, article review, cancer">
    <meta name="author" content="Sarani NATIVEL-SANTERNE">

    <title>HackBio Post - stage 2</title>

    <!-- Bootstrap Core CSS -->
    <link href="css/bootstrap.min.css" rel="stylesheet">

    <!-- Custom CSS -->
    <link href="css/clean-blog.min.css" rel="stylesheet">

    <!-- Custom Fonts -->
    <link href="http://maxcdn.bootstrapcdn.com/font-awesome/4.1.0/css/font-awesome.min.css" rel="stylesheet" type="text/css">
    <link href='http://fonts.googleapis.com/css?family=Lora:400,700,400italic,700italic' rel='stylesheet' type='text/css'>
    <link href='http://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,300,600,700,800' rel='stylesheet' type='text/css'>

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.4.2/respond.min.js"></script>
    <![endif]-->

</head>

<body>

    <!-- Navigation -->
    <nav class="navbar navbar-default navbar-custom navbar-fixed-top">
        <div class="container-fluid">
            <!-- Brand and toggle get grouped for better mobile display -->
            <div class="navbar-header page-scroll">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1">
                    <span class="sr-only">Toggle navigation</span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
                <a class="navbar-brand" href="index.html"><img src="https://raw.githubusercontent.com/Sarani-NS/HackBio-HTML-Project.io/main/img/hackbio-logo.png" alt="HackBio Logo" style="height: 40px;"></a>
            </div>

            <!-- Collect the nav links, forms, and other content for toggling -->
            <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1">
                <ul class="nav navbar-nav navbar-right">
                    <li>
                        <a href="index.html">Home</a>
                    </li>
                    <li>
                        <a href="about.html">About</a>
                    </li>
                    <li>
                        <a href="post.html">The internship</a>
                    </li>
                    <li>
                        <a href="contact.html">Contact</a>
                    </li>
                </ul>
            </div>
            <!-- /.navbar-collapse -->
        </div>
        <!-- /.container -->
    </nav>


    <!-- Page Header -->
    <!-- Set your background image for this header on the line below. -->
    <header class="intro-header" style="background-image: url('https://raw.githubusercontent.com/Sarani-NS/HackBio-HTML-Project.io/main/img/stage2.jpg')">
        <div class="container">
            <div class="row">
                <div class="col-lg-8 col-lg-offset-2 col-md-10 col-md-offset-1">
                    <div class="page-heading">
                        <h1>Innovative Visualization and Reporting of AMR Products Dataset</h1>
                        <hr class="small">
                        <span class="subheading">Insights from the WHO's AMR Products Pipeline</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

<!-- Post Content -->
<article>
    <div class="container">
        <div class="row">
            <div class="col-lg-8 col-lg-offset-2 col-md-10 col-md-offset-1">

                <h3>The Analysis Codes</h3>
                <ul>
                    <li>Data cleaning (in R): <a href="https://github.com/Sarani-NS/HackBio/blob/main/Task2/Analysis%20Code">GitHub Link</a></li>
                    <li>Data processing and visualization (in Python): Link Pending</li>
                </ul>

                <h3>The Infographic</h3>
                <img src="https://github.com/user-attachments/assets/b2b17953-e752-4d7c-9fd7-d3013824712a" alt="Infographic_AMR" class="img-responsive">

                <p>The antimicrobial resistance (AMR) crisis is a major global health threat, with the World Health Organization (WHO) highlighting it as one of the top ten public health challenges. This report provides an overview of the current AMR clinical trials pipeline, focusing on key trends, innovation, pathogen targeting, and developer contributions.</p>

                <p>A significant portion of AMR products are still in the early stages of development. The majority of products are concentrated in Phase I (310), Phase II (186), and Phase III (146), with only 27 products in preregistration as shown in Figure 1. This trend reflects a strong commitment to developing AMR solutions, but it also emphasizes the challenges of advancing products through the later stages due to regulatory, technical, and efficacy hurdles.</p>

                <img src="https://github.com/user-attachments/assets/b1941716-5e24-498d-8d1b-adf75cf89950" alt="Overview of AMR Products" class="img-responsive">
                <p><strong>Figure 1:</strong> Overview of the AMR Products in the Clinical Trials Pipeline.</p>

                <p>Regarding product types, traditional antibiotics dominate the pipeline, with 383 products (57%), while 286 non-traditional therapies (43%) reflect an increasing interest in alternative approaches like bacteriophages, immune modulators, and microbiome-based interventions (Figure 2). The balance between these approaches is expected to evolve as more innovative therapies advance.</p>

                <img src="https://github.com/user-attachments/assets/7d40d70f-cf05-413d-a2df-134758e5f45e" alt="Product Type and Pathogen Targeting Relationships" class="img-responsive">
                <p><strong>Figure 2:</strong> Product Type and Pathogen Targeting Relationships.</p>

                <p>Priority pathogens remain the primary focus of the AMR pipeline, accounting for 95% of the products. However, some pathogens, such as <em>Clostridioides difficile</em> (17 products) and <em>Mycobacterium tuberculosis</em> (14 products), receive relatively less attention, representing opportunities for targeted interventions (Figure 2). Non-traditional therapies for these under-targeted pathogens could play a key role in future development.</p>

                <p>Innovation is a crucial element in addressing AMR, yet only 89 products are considered innovative, while 228 are non-innovative. The relatively small number of innovative products underlines the reliance on traditional solutions. However, the innovative therapies in development hold potential for breakthroughs, such as novel mechanisms of action and immune-boosting approaches.</p>

                <img src="https://github.com/user-attachments/assets/35b14e5c-be3d-450e-8976-fc805b3decc6" alt="Pathogen-Specific Product Types and R&D Phase Distribution" class="img-responsive">
                <p><strong>Figure 3:</strong> Pathogen-Specific Product Types and R&D Phase Distribution.</p>

                <p>Key developers driving AMR product development include Qpex Biopharma, with 39 products, and Wockhardt Ltd., GSK, and Entasis Therapeutics, each contributing 26 products. These companies are critical to ensuring the availability of new treatments for drug-resistant infections (Figure 4).</p>

                <img src="https://github.com/user-attachments/assets/1fc4caa8-9e6b-4f27-bc77-f9326a9f7b43" alt="Top Pathogen-Developer Relationships in AMR Products" class="img-responsive">
                <p><strong>Figure 4:</strong> Top Pathogen-Developer Relationships in AMR Products.</p>

                <p>An analysis of the transition rates between R&D phases reveals that 60% of products move from Phase I to Phase II, while 78.5% advance to Phase III. However, the transition rate from Phase III to preregistration drops sharply to 18.5%, highlighting the risks and challenges associated with late-stage development (Figure 5).</p>

                <img src="https://github.com/user-attachments/assets/0a409cf5-fe1a-4b4c-b96e-401699154aa5" alt="Innovation vs. Product Stage and R&D Pipeline Transition Success Rates" class="img-responsive">
                <p><strong>Figure 5:</strong> Innovation vs. Product Stage and R&D Pipeline Transition Success Rates.</p>

                <p>In conclusion, the AMR clinical trials pipeline shows promise but requires ongoing investment in innovation and advanced-stage products. Supporting key developers and fostering breakthroughs in non-traditional therapies will be crucial in addressing the growing threat of AMR.</p>

                <h3>Contributors Information</h3>
                <table class="table table-bordered">
                    <thead>
                        <tr>
                            <th>Authors</th>
                            <th>Slack ID</th>
                            <th>LinkedIn</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>1</td>
                            <td>@Seebi</td>
                            <td><a href="https://www.linkedin.com/in/haseebmanzoor">LinkedIn Profile</a></td>
                        </tr>
                        <tr>
                            <td>2</td>
                            <td>@YetQiaM</td>
                            <td><a href="https://www.linkedin.com/in/yetunde-alo-mary">LinkedIn Profile</a></td>
                        </tr>
                        <tr>
                            <td>3</td>
                            <td>@Nada_EA</td>
                            <td><a href="https://www.linkedin.com/in/nada-elsayed-ahmed">LinkedIn Profile</a></td>
                        </tr>
                        <tr>
                            <td>4</td>
                            <td>@Sarani</td>
                            <td><a href="https://www.linkedin.com/in/sarani-nativel-santerne">LinkedIn Profile</a></td>
                        </tr>
                        <tr>
                            <td>5</td>
                            <td>@Cipher</td>
                            <td><a href="https://www.linkedin.com/in/nada-elhadidy">LinkedIn Profile</a></td>
                        </tr>
                    </tbody>
                </table>
                
            </div>
        </div>
    </div>
</article>

    <!-- Footer -->
    <footer>
        <div class="container">
            <div class="row">
                <div class="col-lg-8 col-lg-offset-2 col-md-10 col-md-offset-1">
                    <ul class="list-inline text-center">
                        <li>
                            <a href="#">
                                <span class="fa-stack fa-lg">
                                    <i class="fa fa-circle fa-stack-2x"></i>
                                    <i class="fa fa-twitter fa-stack-1x fa-inverse"></i>
                                </span>
                            </a>
                        </li>
                        <li>
                            <a href="#">
                                <span class="fa-stack fa-lg">
                                    <i class="fa fa-circle fa-stack-2x"></i>
                                    <i class="fa fa-facebook fa-stack-1x fa-inverse"></i>
                                </span>
                            </a>
                        </li>
                        <li>
                            <a href="#">
                                <span class="fa-stack fa-lg">
                                    <i class="fa fa-circle fa-stack-2x"></i>
                                    <i class="fa fa-github fa-stack-1x fa-inverse"></i>
                                </span>
                            </a>
                        </li>
                    </ul>
                    <p class="copyright text-muted">Copyright &copy; Sarani NATIVEL-SANTERNE 2024</p>
                </div>
            </div>
        </div>
    </footer>

    <!-- jQuery -->
    <script src="js/jquery.js"></script>

    <!-- Bootstrap Core JavaScript -->
    <script src="js/bootstrap.min.js"></script>

    <!-- Custom Theme JavaScript -->
    <script src="js/clean-blog.min.js"></script>

</body>

</html>
